Scientific substantiation of the model of the drugs' recommended list development for pharmacotherapy of acute bronchitis in children of early age

Authors

DOI:

https://doi.org/10.15587/2519-4852.2017.108325

Keywords:

pharmaceutical maintenance, insurance list, children, acute bronchitis, remedies cost reimbursement

Abstract

Ensuring of the implementation of health sector social standards, in particular, in the aspect of pharmaceutical maintenance of decreed categories of people with free medicines within the regulated list is an important direction of the state policy realization of every country.

Aim. Development of the method for the formation of the recommended list of the basic remedies for early age children and its processing on the model of pharmacotherapy of acute bronchitis.

Methods. System and analytical methods, as well as multi objective optimization problems solution and hierarchy analysis methods were used for the study.

Results. On the basis of systematization of the obtained results of regulatory, marketing and pharmacoeconomic study of medicinal products, the model of formation of the Recommended basic and additional lists of remedies applied for acute simple bronchitis pharmacotherapy in early age children, consisting of seven successive stages, was substantiated and developed. According to the offered model, the Recommended list of the most effective and economically affordable remedies included 24 trade names, including 13 antibacterial, 1 antiviral, 2 immunomodulatory and 8 mucolytic drugs. The share of the national remedies in this list was 20.8 %.

Conclusion. The offered Recommended list of the remedies will help to form local formulary and insurance drug list for pharmacotherapy in early age children under conditions of outpatient and clinic health facilities. At the same time, the given List is a basis for prediction of the future needs for necessary medicines and their cost reimbursement calculation for children under 3 years with acute simple bronchitis, which will help to save budget funds

Author Biographies

Alla Kotvitska, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Doctor of Pharmacy, Professor, Vice-rector for research and educational activities

Ewgenia Korobova, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Postgraduate student

Department of Social Pharmacy

References

  1. Kotviska, A. A., Kubarieva, I. V. (2015). Scientific generalization of modern basis for implementation reimbursement of pharmaceutical care value in European countries. Upravlinnya, ekonomika ta zabezpechennya yakosti v farmatsiyi, 6 (44), 85–89.
  2. Nemchenko, A. S., Simonian, L. S. (2013). Metodychni rekomendatsiyi shchodo rozrobky strakhovykh perelikiv likars'kykh zasobiv dlya likuvannya khvorykh na hryp, uskladnenyy bakterial'noyu pnevmoniyeyu. Kharkiv: NFaU, 27.
  3. Antypkin, Yu. G., Chumachenko, N. G., Umanets, T. R., Lapshin, V. F. (2016). The aspects of respiratory organs pathological conditions dynamics among child population. Sovremennaya Pediatriya, 2 (73), 73–77.
  4. Mainych, Yu. V. (2010). Optymizatsiya likarskoho zabezpechennya ditei z infektsiinymy zakhvoriuvannyamy [Optimization of the medical providing of children is with infectious diseases]. Lviv, 24.
  5. Bieliaieva, O. I. (2015). Optymizatsiya likarskoho zabezpechennia ditei khvorykh na pnevmoniiu [Optimization of medical providing of children with pneumonia]. Nats. med. akad. pislyadyplom. osvity im. P. L. Shupyka. Kyiv, 24.
  6. Vyshnytska, I. V. (2015). Orhanizatsiino-ekonomichne obgruntuvannia likarskoho zabezpechennia khvorykh ditei na hastryt I duodenit [Organizational economic substantiation of the medical providing of sick children with gastritis and duodenitis]. Nats. med. akad. pislyadyplom. osvity im. P. L. Shupyka. Kyiv, 24.
  7. Nemchenko, A. S., Balynska, M. V. (2016). Obgruntuvannia sotsialno-ekonomichnykh perelikiv likarskykh zasobiv dlia likuvannia enterytiv virusnoho pokhodzhennia (virusnykh diarei) u ditei. Kharkiv, 27.
  8. Reviatskyi, I. Yu. (2015). Kompiuteryzatsiia informatsiinoho zabezpechennia farmatsevtychnoi dopomohy dlia ditei ta pidlitkiv [Computerization of the informative providing of pharmaceutical care for children and teenagers]. Lviv, 22.
  9. Pro zatverdzhennya protokoliv nadannya medychnoyi dopomohy dityam za spetsial'nistyu «Dytyacha pul'monolohiya» (2005). Ministry of Health of Ukraine, No. 18. Available at: http://www.moz.gov.ua/ua/portal/dn_20050113_18.html
  10. Pro zatverdzhennya s'omoho vypusku Derzhavnoho formulyara likars'kykh zasobiv ta zabezpechennya yoho dostupnosti (2015). Ministry of Health of Ukraine, No. 183. Available at: http://moz.gov.ua/ua/portal/dn_20160314_0183.html
  11. Derzhavnyi reiestr likarskykh zasobiv Ukrainy. Available at: http://www.drlz.kiev.ua/
  12. Diaby, V., Goeree, R. (2013). How to use multi-criteria decision analysis methods for reimbursement decision-making in healthcare: a step-by-step guide. Expert Review of Pharmacoeconomics & Outcomes Research, 14 (1), 81–99. doi: 10.1586/14737167.2014.859525
  13. Saaty, T. L. (2008). Decision making with the analytic hierarchy process. International Journal of Services Sciences, 1 (1), 83–98. doi: 10.1504/ijssci.2008.017590
  14. Tokarev, V. V. (2011). Metody optimalnyh resheniy. Vol. 2. Mnogokriterialnost. Dinamika. Neopredelennost. Moscow: FIZMATLIT, 420.
  15. Liberatore, M. J., Nydick, R. L. (2008). The analytic hierarchy process in medical and health care decision making: A literature review. European Journal of Operational Research, 189 (1), 194–207. doi: 10.1016/j.ejor.2007.05.001
  16. Lee, C. W., Kwak, N. K. (2009). Strategic Enterprise Resource Planning in a Health-Care System Using a Multicriteria Decision-Making Model. Journal of Medical Systems, 35 (2), 265–275. doi: 10.1007/s10916-009-9362-x

Published

2017-08-31

How to Cite

Kotvitska, A., & Korobova, E. (2017). Scientific substantiation of the model of the drugs’ recommended list development for pharmacotherapy of acute bronchitis in children of early age. ScienceRise: Pharmaceutical Science, (4 (8), 8–14. https://doi.org/10.15587/2519-4852.2017.108325

Issue

Section

Pharmaceutical Science